
New Directions and Practice Impacting Recommendations in Multiple Sclerosis
Faculty presenters: Erin Longbrake, MD, PhD (Meeting Chair and Publication Editor); Stephen Krieger, MD; Carrie M. Hersh, DO, MSc, FAAN; Jens Kuhle, MD, PhD; Pascal Sati, PhD; Robert T. Naismith, MD; Fredrik Piehl, MD; Riley Bove, MD; and Ahmed Z. Obeidat, MD.
This NeurologyLive supplement comprises 3 articles that review the evolving biological understanding of multiple sclerosis (MS) and the associated implications for treatment. The publication also explores emerging biomarkers in MS as well as the latest ideas on the use of disease-modifying therapies, including scenarios for starting, switching, or stopping immunotherapy.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Approves Tavapadon for the Treatment of Parkinson Disease
2
FDA Accepts Fenebrutinib NDA Under Priority Review for Relapsing and Primary Progressive MS
3
ADHERE REAL Study to Assess Real-World Effectiveness of Efgartigimod in CIDP
4
Phase 4 OCTAGON Trial to Test Rapid Steroid Taper With Ravulizumab
5
